glp 1 retinopathy A study in JAMA Network Open adds to the growing evidence connecting GLP1 receptor agonist drugs with diabetic retinopathy. In people with type 2 diabetes, the study found a 7% increased risk A Critical Eye on GLP-1

2022 Jan

Complex Development and Manufacturing GLP-1 medicines are not simple chemical compounds

[10] Ipamorelin, based on experimental data, might also elevate growth hormone secretion levels to approximately 80 mIU/l, which appears to be 60 times higher than the levels observed following test model exposure to a placebo

Antagonism occurs in combination pharmacology, and where mechanisms overlap, pathway saturation can make additional components contribute less than expected

Sessions will explore key macroeconomic themes and the trends shaping business activity in the year ahead

Yawning/stretching reflex documented mechanism finding for melanocortin agonists